-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Reiterates Outperform on Hologic, Lowers Price Target to $71

Benzinga·05/02/2025 16:30:12
Listen to the news
Raymond James analyst Andrew Cooper reiterates Hologic (NASDAQ:HOLX) with a Outperform and lowers the price target from $90 to $71.